Trial Profile
A phase III study of low-dose testosterone gel [LibiGel] in naturally postmenopausal women with sexual dysfunction.
Status:
Recruiting
Phase of Trial:
Phase III
Latest Information Update: 06 Jun 2008
Price :
$35
*
At a glance
- Drugs Testosterone (Primary)
- Indications Female sexual dysfunction
- Focus Registrational; Therapeutic Use
- Sponsors ANI Pharmaceuticals
- 06 Jun 2008 New trial record.